ZENOX HEALTH LIMITED

Company Registration Number:
NI051914 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

ZENOX HEALTH LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

ZENOX HEALTH LIMITED

Balance sheet

As at 31 December 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 77,369 76,615
Total fixed assets: 77,369 76,615
Current assets
Stocks: 1,837,264 2,152,651
Debtors:   35,747 136,547
Cash at bank and in hand: 61,753 54,390
Total current assets: 1,934,764 2,343,588
Creditors: amounts falling due within one year: 4 (641,097) (837,421)
Net current assets (liabilities): 1,293,667 1,506,167
Total assets less current liabilities: 1,371,036 1,582,782
Creditors: amounts falling due after more than one year: 5 (320,964) (411,939)
Provision for liabilities: (13,635) (13,475)
Total net assets (liabilities): 1,036,437 1,157,368
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 1,036,436 1,157,367
Shareholders funds: 1,036,437 1,157,368

The notes form part of these financial statements

ZENOX HEALTH LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 September 2024
and signed on behalf of the board by:

Name: MR MARK N ARMSTRONG
Status: Director

The notes form part of these financial statements

ZENOX HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ZENOX HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 2022
Average number of employees during the period 18 20

ZENOX HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Tangible Assets

Total
Cost £
At 01 January 2023 137,051
Additions 14,771
At 31 December 2023 151,822
Depreciation
At 01 January 2023 60,436
Charge for year 14,017
At 31 December 2023 74,453
Net book value
At 31 December 2023 77,369
At 31 December 2022 76,615

ZENOX HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Creditors: amounts falling due within one year note

The company's bank loan and overdraft are secured on the company's assets.

ZENOX HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

5. Creditors: amounts falling due after more than one year note

The company's bank loan and overdraft are secured on the company's assets.